1. Academic Validation
  2. Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease

Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease

  • Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1157-1170. doi: 10.1016/j.bbadis.2017.03.017.
Magdalena J Kiprowska 1 Anna Stepanova 2 Dustin R Todaro 3 Alexander Galkin 4 Arthur Haas 3 Scott M Wilson 5 Maria E Figueiredo-Pereira 6
Affiliations

Affiliations

  • 1 Department of Biological Sciences, Hunter College, Biology and Biochemistry Programs, Graduate Center, The City University of New York, New York, NY 10065, USA.
  • 2 School of Biological Sciences, Queen's University Belfast, Belfast BT9 7BL, United Kingdom; N.K. Koltzov Institute of Developmental Biology, Russian Academy of Sciences, Moscow 119334, Russia.
  • 3 Department of Biochemistry and Molecular Biology, LSU Health Sciences Center, New Orleans, LA 70112, USA.
  • 4 School of Biological Sciences, Queen's University Belfast, Belfast BT9 7BL, United Kingdom; Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY 10065, USA.
  • 5 Department of Neurobiology, Civitan International Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • 6 Department of Biological Sciences, Hunter College, Biology and Biochemistry Programs, Graduate Center, The City University of New York, New York, NY 10065, USA. Electronic address: [email protected].
Abstract

In Alzheimer's disease Proteasome activity is reportedly downregulated, thus increasing it could be therapeutically beneficial. The proteasome-associated Deubiquitinase USP14 disassembles polyubiquitin-chains, potentially delaying proteasome-dependent protein degradation. We assessed the protective efficacy of inhibiting or downregulating USP14 in rat and mouse (Usp14axJ) neuronal cultures treated with prostaglandin J2 (PGJ2). IU1 concentrations (HIU1>25μM) reported by Others to inhibit USP14 and be protective in non-neuronal cells, reduced PGJ2-induced Ub-protein accumulation in neurons. However, HIU1 alone or with PGJ2 is neurotoxic, induces calpain-dependent Tau cleavage, and decreases E1~Ub thioester levels and 26S Proteasome assembly, which are energy-dependent processes. We attribute the two latter HIU1 effects to ATP-deficits and mitochondrial Complex I inhibition, as shown herein. These HIU1 effects mimic those of mitochondrial inhibitors in general, thus supporting that ATP-depletion is a major mediator of HIU1-actions. In contrast, low IU1 concentrations (LIU1≤25μM) or USP14 knockdown by siRNA in rat cortical cultures or loss of USP14 in cortical cultures from ataxia (Usp14axJ) mice, failed to prevent PGJ2-induced Ub-protein accumulation. PGJ2 alone induces Ub-protein accumulation and decreases E1~Ub thioester levels. This seemingly paradoxical result may be attributed to PGJ2 inhibiting some deubiquitinases (such as UCH-L1 but not USP14), thus triggering Ub-protein stabilization. Overall, IU1-concentrations that reduce PGJ2-induced accumulation of Ub-proteins are neurotoxic, trigger calpain-mediated Tau cleavage, lower ATP, E1~Ub thioester and E1 protein levels, and reduce Proteasome activity. In conclusion, pharmacologically inhibiting (with low or high IU1 concentrations) or genetically down-regulating USP14 fail to enhance proteasomal degradation of Ub-proteins or Tau in neurons.

Keywords

Alzheimer's; Calpain; Deubiquitinase; Mitochondria; Tau; USP14; Ubiquitin-activating enzyme.

Figures
Products